The 1,1a,2,7b-tetrahydrocyclopropa[
c
]chromene,
arising from fusion of chromane and cyclopropane rings is the core
of medicinally relevant compounds. Engaging sulfoxonium ylides in
enantioselective aminocatalytic reactions for the first time, a convenient
entry to this scaffold is presented. Several ring-fused derivatives
were obtained in moderate-to-good yields and enantioselectivities
and with perfect diastereoselectivity at the cyclopropane, using an
α,α-diphenylprolinol aminocatalyst. The versatility of
the hemiacetal moiety in the products was leveraged to effect various
synthetic manipulations.